103 related articles for article (PubMed ID: 33550915)
21. Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer.
Song L; Wang S; Li Q; Lu Y; Yang R; Feng X
J Oncol; 2023; 2023():9931419. PubMed ID: 36936373
[TBL] [Abstract][Full Text] [Related]
22. Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker.
Zhou Y; Gao M; Jing Y; Wang X
Front Genet; 2022; 13():1032382. PubMed ID: 36685968
[No Abstract] [Full Text] [Related]
23. Positive Expression of Retinol-Binding Protein 4 Is Related to the Malignant Clinical Features Leading to Poor Prognosis of Glioblastoma.
Deng X; Ren J; Bi Z; Fu Z
Genet Res (Camb); 2022; 2022():5435523. PubMed ID: 36632438
[TBL] [Abstract][Full Text] [Related]
24. Proteomes of Residual Tumors in Curcumin-Treated Rats Reveal Changes in Microenvironment/Malignant Cell Crosstalk in a Highly Invasive Model of Mesothelioma.
Pouliquen DL; Malloci M; Boissard A; Henry C; Guette C
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430209
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer.
Ku SC; Liu HL; Su CY; Yeh IJ; Yen MC; Anuraga G; Ta HDK; Chiao CC; Xuan DTM; Prayugo FB; Wang WJ; Wang CY
Aging (Albany NY); 2022 Oct; 14(20):8498-8567. PubMed ID: 36315446
[TBL] [Abstract][Full Text] [Related]
26. DIRAS3, GPR171 and RAC2 were identified as the key molecular patterns associated with brain metastasis of breast cancer.
Dai J; Chen Q; Li G; Chen M; Sun H; Yan M
Front Oncol; 2022; 12():965136. PubMed ID: 36212434
[TBL] [Abstract][Full Text] [Related]
27. Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review).
Flores-Cortez YA; Barragán-Bonilla MI; Mendoza-Bello JM; González-Calixto C; Flores-Alfaro E; Espinoza-Rojo M
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35656886
[TBL] [Abstract][Full Text] [Related]
28. Early Breast Cancer Evolution by Autosomal Broad Copy Number Alterations.
Larsen JR; Kuhn P; Hicks JB
Int J Genomics; 2022; 2022():9332922. PubMed ID: 35252434
[TBL] [Abstract][Full Text] [Related]
29. Epigenome-Wide DNA Methylation Profiling in Colorectal Cancer and Normal Adjacent Colon Using Infinium Human Methylation 450K.
Baharudin R; Ishak M; Muhamad Yusof A; Saidin S; Syafruddin SE; Wan Mohamad Nazarie WF; Lee LH; Ab Mutalib NS
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054365
[TBL] [Abstract][Full Text] [Related]
30. The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer.
Martínez-Pérez C; Kay C; Meehan J; Gray M; Dixon JM; Turnbull AK
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834425
[TBL] [Abstract][Full Text] [Related]
31. The Lipocalin Apolipoprotein D Functional Portrait: A Systematic Review.
Sanchez D; Ganfornina MD
Front Physiol; 2021; 12():738991. PubMed ID: 34690812
[TBL] [Abstract][Full Text] [Related]
32. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers in Breast Cancer: An Old Story with a New End.
Neves Rebello Alves L; Dummer Meira D; Poppe Merigueti L; Correia Casotti M; do Prado Ventorim D; Ferreira Figueiredo Almeida J; Pereira de Sousa V; Cindra Sant'Ana M; Gonçalves Coutinho da Cruz R; Santos Louro L; Mendonça Santana G; Erik Santos Louro T; Evangelista Salazar R; Ribeiro Campos da Silva D; Stefani Siqueira Zetum A; Silva Dos Reis Trabach R; Imbroisi Valle Errera F; de Paula F; de Vargas Wolfgramm Dos Santos E; Fagundes de Carvalho E; Drumond Louro I
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510269
[TBL] [Abstract][Full Text] [Related]
34. A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling.
Arana Echarri A; Beresford M; Campbell JP; Jones RH; Butler R; Gollob KJ; Brum PC; Thompson D; Turner JE
Front Immunol; 2020; 11():616188. PubMed ID: 33597950
[TBL] [Abstract][Full Text] [Related]
35. Identification of Novel Biomarkers Associated With the Prognosis and Potential Pathogenesis of Breast Cancer via Integrated Bioinformatics Analysis.
Wu M; Li Q; Wang H
Technol Cancer Res Treat; 2021; 20():1533033821992081. PubMed ID: 33550915
[TBL] [Abstract][Full Text] [Related]
36. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
37. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
